These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1269 related items for PubMed ID: 18824555

  • 1. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK, Stokkers PC, van Bodegraven AA, van Hogezand RA, Verspaget HW, de Jong DJ, van der Woude CJ, Oldenburg B, Linskens RK, Festen EA, van der Steege G, Hommes DW, Crusius JB, Wijmenga C, Nolte IM, Dijkstra G, Dutch Initiative on Crohn and Colitis (ICC).
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [Abstract] [Full Text] [Related]

  • 2. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M, Göke B, Folwaczny C, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [Abstract] [Full Text] [Related]

  • 3. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
    Oostenbrug LE, Nolte IM, Oosterom E, van der Steege G, te Meerman GJ, van Dullemen HM, Drenth JP, de Jong DJ, van der Linde K, Jansen PL, Kleibeuker JH.
    Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
    [Abstract] [Full Text] [Related]

  • 4. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K, Boor PP, Houwing-Duistermaat JJ, Crusius BJ, Wilson PJ, Kuipers EJ, de Rooij FW.
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [Abstract] [Full Text] [Related]

  • 5. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J, Konrad A, Schmechel S, Dambacher J, Seiderer J, Schroff F, Wetzke M, Roeske D, Török HP, Tonenchi L, Pfennig S, Haller D, Griga T, Klein W, Epplen JT, Folwaczny C, Lohse P, Göke B, Ochsenkühn T, Mussack T, Folwaczny M, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [Abstract] [Full Text] [Related]

  • 6. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V, Maconi G, Ardizzone S, Colombo E, Ferrara E, Russo A, Tenchini ML, Porro GB.
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [Abstract] [Full Text] [Related]

  • 7. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A, Palmieri O, Valvano MR, D'Incà R, Caprilli R, Cucchiara S, Sturniolo GC, Bossa F, Andriulli A, Annese V.
    Aliment Pharmacol Ther; 2008 Feb 01; 27(3):241-8. PubMed ID: 17944996
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
    Büning C, Schmidt HH, Molnar T, De Jong DJ, Fiedler T, Bühner S, Sturm A, Baumgart DC, Nagy F, Lonovics J, Drenth JP, Landt O, Nickel R, Büttner J, Lochs H, Witt H.
    Aliment Pharmacol Ther; 2007 Oct 01; 26(7):1025-33. PubMed ID: 17877509
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genetic risk profiling and gene signature modeling to predict risk of complications after IPAA.
    Sehgal R, Berg A, Polinski JI, Hegarty JP, Lin Z, McKenna KJ, Stewart DB, Poritz LS, Koltun WA.
    Dis Colon Rectum; 2012 Mar 01; 55(3):239-48. PubMed ID: 22469789
    [Abstract] [Full Text] [Related]

  • 12. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians.
    Juyal G, Amre D, Midha V, Sood A, Seidman E, Thelma BK.
    Aliment Pharmacol Ther; 2007 Nov 15; 26(10):1325-32. PubMed ID: 17892524
    [Abstract] [Full Text] [Related]

  • 13. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
    Molnar T, Hofner P, Nagy F, Lakatos PL, Fischer S, Lakatos L, Kovacs A, Altorjay I, Papp M, Palatka K, Demeter P, Tulassay Z, Nyari T, Miheller P, Papp J, Mandi Y, Lonovics J, Hungarian IBD Study Group.
    Dig Liver Dis; 2007 Dec 15; 39(12):1064-70. PubMed ID: 17964870
    [Abstract] [Full Text] [Related]

  • 14. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.
    Okazaki T, Wang MH, Rawsthorne P, Sargent M, Datta LW, Shugart YY, Bernstein CN, Brant SR.
    Inflamm Bowel Dis; 2008 Nov 15; 14(11):1528-41. PubMed ID: 18521914
    [Abstract] [Full Text] [Related]

  • 15. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
    Glas J, Stallhofer J, Ripke S, Wetzke M, Pfennig S, Klein W, Epplen JT, Griga T, Schiemann U, Lacher M, Koletzko S, Folwaczny M, Lohse P, Göke B, Ochsenkühn T, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2009 Jul 15; 104(7):1737-44. PubMed ID: 19455118
    [Abstract] [Full Text] [Related]

  • 16. Hla-B genotype in Japanese patients with Crohn's disease.
    Kinouchi Y, Matsumoto K, Negoro K, Takagi S, Takahashi S, Hiwatashi N, Shimosegawa T.
    Dis Colon Rectum; 2003 Oct 15; 46(10 Suppl):S10-4. PubMed ID: 14530653
    [Abstract] [Full Text] [Related]

  • 17. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease.
    Noble CL, Nimmo ER, Drummond H, Ho GT, Tenesa A, Smith L, Anderson N, Arnott ID, Satsangi J.
    Gastroenterology; 2005 Dec 15; 129(6):1854-64. PubMed ID: 16344054
    [Abstract] [Full Text] [Related]

  • 18. Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
    Alvarez-Lobos M, Arostegui JI, Sans M, Tassies D, Piu J, Reverter JC, Pique JM, Yagüe J, Panés J.
    Aliment Pharmacol Ther; 2007 Feb 15; 25(4):429-40. PubMed ID: 17269998
    [Abstract] [Full Text] [Related]

  • 19. Genetic variation in DLG5 is associated with inflammatory bowel disease.
    Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, Koch WA, Rosenstiel P, Albrecht M, Croucher PJ, Seegert D, Nikolaus S, Hampe J, Lengauer T, Pierrou S, Foelsch UR, Mathew CG, Lagerstrom-Fermer M, Schreiber S.
    Nat Genet; 2004 May 15; 36(5):476-80. PubMed ID: 15107852
    [Abstract] [Full Text] [Related]

  • 20. TUCAN (CARD8) genetic variants and inflammatory bowel disease.
    McGovern DP, Butler H, Ahmad T, Paolucci M, van Heel DA, Negoro K, Hysi P, Ragoussis J, Travis SP, Cardon LR, Jewell DP.
    Gastroenterology; 2006 Oct 15; 131(4):1190-6. PubMed ID: 17030188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.